Archives by Month:
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- January 2024
- December 2023
- November 2023
- October 2023
- August 2023
- July 2023
- June 2023
- May 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- July 2016
- June 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- November 2012
- October 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- June 2009
- April 2009
- February 2009
- December 2008
- November 2008
- October 2008
- August 2008
- June 2008
- May 2008
Archives by Year:
Aurora Cannabis Is Quickly Growing Into A Canadian Cannabis Conglomerate
Aurora Cannabis Inc. (ACB.TO) (ACBFF) continues to execute on all cylinders and put its capital to work. The licensed Canadian medical marijuana producer has over $300 million of cash on hand and the company has been using its stock as a currency to make strategic investments and acquisitions. Although Aurora has been making significant moves […]
Buy Gold As Fed Shows Uncertainty And Concern Over Financial ‘Imbalances’
– FOMC minutes show uncertainty and concern about markets are affecting officials’ decision-making – Officials were cautious when evaluating market conditions and the ‘damaging effects on the economy’ – Worry about ‘potential buildup of financial imbalances’ and a sharp reversal in asset prices’ – Members seem oblivious to impact of inflation on households and savings […]
‘The Enigma Of 8’: Here’s What Goldman Sees For China’s Markets In 2018
Goldman knows one thing for sure about Chinese equities in 2018 and that’s this: But, one thing we could say confidently: our current 2018 views are unlikely to stay unchanged as we go through the year. So you know, they might as well have just put a big “take this with a grain of salt” […]
The Pros And Cons Of Trading Penny Stocks
Let’s face it, we’ve all heard the stories of rags to riches in the investment world. More often than not, these stories come from some sort of transaction involving a penny stock. We’ve all probably seen Wolf of Wall Street, but we all can’t be Jordan Belfort. Most of the people who choose to go […]
Invest In Stocks? Depends On Where You Live
from the St Louis Fed Stock market participation varies widely by income, with higher-income families being more likely to own stocks. But what about by state? A recent article in The Regional Economist found that stock market participation varied across the country as well, even among households of similar incomes. Senior Economist YiLi Chien and Senior Research Associate Paul Morris examined […]
Tough Love On Saving For Retirement (For Millennials)
Periodically, I read articles that appear antithetical to the premise of paying yourself first and saving as much as you can, as early as you can to have enough saved for retirement. In the last few weeks, I’ve read two articles – one saying that traditional retirement savings for millennials is useless, and the other saying […]
E Target’s Q4 2017 Guidance: Was Brian Cornell Being Too Cautious?
Chugga-chugga, chugga-chugga, chugga-chugga choo choo! That’s what I think when I consider Target Corporation (TGT) through 2017 and, in fact, over the last few years. The retailer keeps chugging along with various fits and starts and all the while with a share price that has gone nowhere in the last few years. Target “thinks it […]
Tech-Stock Momentum Accelerates
Technology shares have surged recently, leaving the rest of US equity sectors in the dust, based on a set of ETFs. Sector leadership appeared to be shifting to tech from financials at the end of last month. Nearly four weeks later, the transition is complete and there’s no doubt which sector dominates the upside momentum rankings for […]
3 Top-Ranked Mutual Funds From JP Morgan
JPMorgan is one of the best financial management companies in the world. It has a legacy of investment management since 1865. Also, JPMorgan is the eighth-largest mutual fund firm in the United States and prides itself as the nation’s leader in equity fund flows. JPMorgan offers managed accounts and retirement products. The company has pioneered […]
Deutsche Cuts Merck Target To $59 On Competition From AbbVie, GSK
Deutsche Bank analyst Gregg Gilbert lowered his price target for Merck (MRK) to $59 from $62 citing expectations for more competitive pressure on Zepatier and Zostavax. The stock closed Wednesday up 10c to $54.37. Demand trends for Merck’s hepatitis C virus drug Zepatier have continued to decline as AbbVie’s (ABBV) Mavyret has gained traction, […]
